Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause

Journal of clinical medicine, 8(1), E1, 2018

Abstract

This report presents the case of a woman aged 40 who has experienced premature menopause from the age of 35. Having rejected oocyte donation, she opted for intraovarian injection of autologous platelet-rich plasma with the aim to rejuvenate the ovarian tissue and enable the employment of her own gametes through in-vitro fertilization. Six weeks following the autologous platelet-rich plasma treatment, a significant reduction in the patient's follicle-stimulating hormone (FSH) levels were noted. A natural in-vitro fertilization cycle led to a biochemical pregnancy, resulting in a spontaneous abortion at the 5th week of pregnancy. This is the first report of a successful autologous platelet-rich plasma application leading to pregnancy in menopause. This report uniquely contributes to the medical knowledge and challenges current practice in the context of infertility. The efficiency and safety of this treatment with regard to the reproductive system merits further investigation.

platelet rich plasma ovarian rejuvenation, PRP treatment premature menopause, premature ovarian insufficiency PRP, intraovarian platelet rich plasma, ovarian rejuvenation therapy, POI premature ovarian insufficiency treatment, early menopause fertility treatment, autologous PRP ovarian function, FSH reduction premature menopause, ovarian tissue rejuvenation, experimental infertility treatments POI

Sfakianoudis, K., Simopoulou, M., Nitsos, N., Rapani, A., Pappas, A., Pantou, A., Koutsilieris, M., Pantos, K., Chronopoulou, M., & Deligeoroglou, E. (2018). Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause. *Journal of clinical medicine*, *8*(1), E1. https://doi.org/10.3390/jcm8010001